Account wins from 03/17/06 News Brief

Mc|K Healthcare has been retained by Critical Therapeutics of Lexington, MA, for the professional marketing and promotion of Zyflo (zileuton tablets). Zyflo was approved by the FDA in Sept. 2005 for the prevention and chronic treatment of asthma in adults and children 12 years of age and older.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions